TWO-YEAR ADMINISTRATION DATA OF AN ORAL TESTOSTERONE UNDECANOATE (TU) FORMULATION IN HYPOGONADAL MEN

被引：0

作者：

Swerdloff, R. ^{[1
]}

Honig, S. ^{[2
]}

Wang, C. ^{[1
]}

Gittelman, M. ^{[3
]}

Sea, B. W. ^{[4
]}

Rohowsky, N. ^{[5
]}

Dudley, R. ^{[1
]}

机构：

[1] Lundquist Inst Harbor UCLA, Los Angeles, CA USA

[2] Yale Sch Med, New Haven, CT USA

[3] UroMedix & South Florida Med Res, Aventura, FL USA

[4] Clarus Therapeut, Northbrook, IL USA

[5] Integrated Data Consultat Serv Inc, Bellrosemanor, NY USA

来源：

JOURNAL OF SEXUAL MEDICINE | 2022年 / 19卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S2 / S2

页数：1

共 50 条

[41] TREATMENT OF HYPOGONADAL MALE PATIENTS WITH ORAL TESTOSTERONE UNDECANOATE - PRELIMINARY COMMUNICATION
SKARABALO, Z
METELKO, Z
ROCIC, B
INTERNATIONAL JOURNAL OF ANDROLOGY, 1978, : 150 - 150
[42] LONG-TERM STUDY OF ORAL TESTOSTERONE UNDECANOATE IN HYPOGONADAL MALES
FRANCHI, F
LUISI, M
KICOVIC, PM
INTERNATIONAL JOURNAL OF ANDROLOGY, 1978, 1 (03): : 270 - 278
[43] Incidence and severity of prostate cancer in 360 hypogonadal men treated with testosterone undecanoate injections (TU) for up to 8 years and 296 untreated hypogonadal controls.
Haider, Ahmad
Haider, Karim Sultan
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[44] Incidence and severity of prostate cancer in 375 hypogonadal men treated with testosterone undecanoate injections (TU) for up to 10 years and 296 untreated hypogonadal controls.
Haider, Ahmad
Haider, Karim Sultan
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[45] PROSTATE CANCER IS LESS FREQUENT AND SEVERE IN HYPOGONADAL MEN TREATED ADEQUATELY WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) FOR UP TO 8 YEARS COMPARED TO UNTREATED HYPOGONADAL CONTROLS
Haider, Ahmad
Haider, Karim Sultan
Doros, Gheorghe
Traish, Abdulmaged
JOURNAL OF UROLOGY, 2016, 195 (04): : E236 - E236
[46] Comparison of Long-Acting Testosterone Undecanoate Formulation Versus Testosterone Enanthate on Sexual Function and Mood in Hypogonadal Men Editorial Comment
Seftel, Allen
JOURNAL OF UROLOGY, 2009, 182 (04): : 1508 - 1509
[47] Metabolic Syndrome Parameters in Hypogonadal Men on Long-Term Treatment with Testosterone Undecanoate (TU) Injections Improve Independently from Age: Observational Data from Two Registry Studies
Yassin, Aksam A.
Haider, Ahmad
Doros, Gheorghe
Traish, Abdulmaged M.
Saad, Farid
ENDOCRINE REVIEWS, 2014, 35 (03)
[48] ASSESSMENT OF FASTING AND VARYING MEAL FAT CONTENT ON THE BIOAVAILABILITY OF ORAL TESTOSTERONE UNDECANOATE (LPCN 1021) IN HYPOGONADAL MEN
Khera, M.
Dobs, A. S.
Miner, M. M.
Wang, C.
Delconte, A.
Chidambaram, N.
Nachaegari, S.
Patel, M.
JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S18 - S18
[49] INITIATING HIGH-DOSE ORAL TESTOSTERONE UNDECANOATE THERAPY IN HYPOGONADAL MEN: SAFETY, EFFICACY, AND PATIENT SATISFACTION
Vo, J.
Yoon, G.
Sun, A. Y.
JOURNAL OF SEXUAL MEDICINE, 2024, 21
[50] ERECTILE FUNCTION IN 164 MATCHED HYPOGONADAL MEN: RESULTS OF LONG TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) IN COMPARISON WITH CONTROL GROUP
Haider, K. S.
Haider, A.
Doros, G.
Traish, A.
JOURNAL OF SEXUAL MEDICINE, 2017, 14 (01): : S3 - S3

← 1 2 3 4 5 →